Phenotypic and Serotypic Characterization of Staphylococcus aureus Strains from Subclinical Mastitis Cattle (KARAKTERISASI SECARA FENOTIPE DAN SEROTIPE STAPHYLOCOCCUS AUREUS YANG BERASAL DARI MASTITIS SUBKLINIK PADA SAPI) | Zendy

Siti Gusti Ningrum | Zendy; Wyanda Arnafia | Zendy; Sylvia Oscarina | Zendy; Retno Damajanti Soejoedono | Zendy; Hadri Latif | Zendy; Mohammad Javad Ashraf | Zendy; I Wayan Teguh Wibawan | Zendy

Open Access

Phenotypic and Serotypic Characterization of Staphylococcus aureus Strains from Subclinical Mastitis Cattle (KARAKTERISASI SECARA FENOTIPE DAN SEROTIPE STAPHYLOCOCCUS AUREUS YANG BERASAL DARI MASTITIS SUBKLINIK PADA SAPI)

Author(s) -

Siti Gusti Ningrum,

Wyanda Arnafia,

Sylvia Oscarina,

Retno Damajanti Soejoedono,

Hadri Latif,

Mohammad Javad Ashraf,

I Wayan Teguh Wibawan

Publication year - 2016

Publication title -

jurnal veteriner

Language(s) - English

Resource type - Journals

eISSN - 2477-5665

pISSN - 1411-8327

DOI - 10.19087/jveteriner.2016.17.1.112

Subject(s) - staphylococcus aureus , microbiology and biotechnology , ciprofloxacin , cefepime , mastitis , biology , nitrofurantoin , antibiotics , amikacin , enrofloxacin , california mastitis test , bacteria , antibiotic resistance , lactation , imipenem , genetics , pregnancy , ice calving

Staphylococcus aureus is known as a major causative agent of mastitis in dairy cattle. In the presentstudy, 104 isolates of Staphlylococcus originated from subclinical mastitis cattle characterized for thephenotypic properties and the presence of Staphylococcal protein A (Spa). Some bacteria were resistancesagainst several antibiotics were also studied, such as, streptomycin, cefepime, nitrofurantoin, amikacin,chloramphenicol, and ciprofloxacin. About 78% of the isolated were moderately sensitive to nitrofurantoin,while 89% were highly resistant to cefepime and ciprofloxacin. Using the various mammals’ sera, sevenisolates revealed the presence of Spa.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research